• Register
  • Login
    • en
    • ru
    • uz
  • en
  • ru
  • uz
Register Login
  • Current
  • Archives
    • About the Journal
    • Submissions
    • Editorial Masthead
    • Privacy Statement
    • Contact
Current Archives
About the Journal Submissions Editorial Masthead Privacy Statement Contact
  1. Home
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

Found one item.
  • COMPARATIVE EFFICACY AND SAFETY OF BARICITINIB PLUS SULFASALAZINE VERSUS TNF-Α INHIBITORS AND SULFASALAZINE MONOTHERAPY IN REACTIVE ARTHRITIS: A 12-MONTH RANDOMIZED STUDY

    Mullokulov J.J., Akhmedov Kh.S.

    Reactive arthritis (ReA) is a post-infectious spondyloarthritis characterized by arthritis, enthesitis, and extra-articular features. Conventional treatments such as sulfasalazine (SSZ) show modest benefit, while TNF-α inhibitors are effective but limited by cost and accessibility. Baricitinib, a JAK1/2 inhibitor, offers a novel oral therapeutic strategy, though evidence in ReA is scarce.

    21-26
    18-10-2025
    Read more
1 - 1 of 1 items

Information

  • For Readers
  • For Authors
  • For Librarians

Latest publications

  • Atom logo
  • RSS2 logo
  • RSS1 logo
TNMU Publishing

We bring together researchers, knowledge, and technology to accelerate medical progress and improve public health.

 

Navigation

Home
Journals
Conferences
To Authors
To Reviewers
Publishing services

Support

Guidelines for authors
Publication ethics
About us
FAQ
Feedback

Contacts

 
Uzbekistan, Tashkent,
Almazar District, Shifokorlar, 21
 
(+998) 91 164 24 40
 
publishing@tnmu.uz
© Copyright 2026 TNMU Publishing All Rights Reserved | Developed by in Science | Site create by in Designer
Login
Bulletin of the Association of Pulmonologists of Central Asia
Login
* Required
* Required
Forgot your password?
Keep me logged in
Register